Missing/wrong data?
Log in to edit
Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial
scientific article published on 18 August 2003
Author/s
author: Judith S Hochman, Paul W. Armstrong, Christopher B. Granger, Kenneth W Mahaffey, Witold Rużyłło, Pierre Théroux, Thomas G. Todaro, W. Douglas Weaver
Work details
Publication date
August 18, 2003
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.